| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |